This inventor holds 3 USPTO granted patents and 2 published patent applications. Top assignee: New York University. Active years: 2021-2026.
Company Filing History:
Years Active: 2021-2026
Title: Innovations of Craig Ramirez
Introduction
Craig Ramirez is an accomplished inventor based in Short Hills, NJ (US). He has made significant contributions to the field of macrophage research, holding 3 patents that focus on methods and reagents for modulating macrophage phenotype. His work is pivotal in understanding how to induce phenotypic changes in monocytes and macrophages, which can have important implications in medical research and treatment.
Latest Patents
Ramirez's latest patents include innovative methods for inducing a phenotypic change in a population of monocytes and/or macrophages. The first patent describes a method that involves administering a macrophage stimulating agent coupled to a carrier molecule. This carrier molecule facilitates macropinocytic uptake of the agent by monocytes and macrophages, while being defective in neonatal Fc receptor binding. This administration induces a phenotypic change in the monocytes and macrophages in the population. The second patent mirrors the first, emphasizing the importance of these methods in modulating immune responses.
Career Highlights
Craig Ramirez is affiliated with New York University, where he continues to advance his research in macrophage biology. His work has garnered attention for its potential applications in therapeutic strategies, particularly in the context of immune modulation.
Collaborations
Ramirez collaborates with notable colleagues such as Dafna Bar-Sagi and Jane Cullis, who contribute to the interdisciplinary approach of his research. Their combined expertise enhances the impact of their work in the scientific community.
Conclusion
Craig Ramirez is a notable inventor whose work in macrophage phenotype modulation is paving the way for future innovations in medical research. His contributions are essential for advancing our understanding of immune responses and developing new therapeutic strategies.